These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10993115)

  • 1. Comparison of [3H]tamsulosin and [3H]prazosin binding to wild-type and constitutively active alpha1B-adrenoceptors.
    Hein P; Goepel M; Cotecchia S; Michel MC
    Life Sci; 2000 Jun; 67(5):503-8. PubMed ID: 10993115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential alpha1-adrenoceptor labeling by [3H]prazosin and [3H]tamsulosin.
    Michel MC; Goepel M
    Eur J Pharmacol; 1998 Jan; 342(1):85-92. PubMed ID: 9544796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of guinea-pig, bovine and rat alpha 1-adrenoceptor subtypes.
    Büscher R; Heeks C; Taguchi K; Michel MC
    Br J Pharmacol; 1996 Feb; 117(4):703-11. PubMed ID: 8646417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on pharmacokinetics and in vivo alpha1-adrenoceptor binding of [3H]tamsulosin and [3H]prazosin in rats.
    Ohkura T; Yamada S; Deguchi Y; Kimura R
    Biol Pharm Bull; 1999 Apr; 22(4):412-7. PubMed ID: 10328564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
    Murata S; Taniguchi T; Muramatsu I
    Br J Pharmacol; 1999 May; 127(1):19-26. PubMed ID: 10369451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors.
    Hein P; Goepel M; Cotecchia S; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):34-9. PubMed ID: 11191834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate.
    Hiraoka Y; Ohmura T; Oshita M; Watanabe Y; Morikawa K; Nagata O; Kato H; Taniguchi T; Muramatsu I
    Eur J Pharmacol; 1999 Jan; 366(1):119-26. PubMed ID: 10064160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]R-terazosin binds selectively to alpha1-adrenoceptors over alpha2-adrenoceptors - comparison with racemic [3H]terazosin and [3H]prazosin.
    Ireland LM; Cain JC; Rotert G; Thomas S; Shoghi S; Hancock AA; Kerwin JF
    Eur J Pharmacol; 1997 May; 327(1):79-86. PubMed ID: 9185839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tamsulosin metabolites at alpha-1 adrenoceptor subtypes.
    Taguchi K; Saitoh M; Sato S; Asano M; Michel MC
    J Pharmacol Exp Ther; 1997 Jan; 280(1):1-5. PubMed ID: 8996174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo occupancy by tamsulosin of alpha1-adrenoceptors in rat tissues in relation to the plasma concentration.
    Ohkura T; Yamada S; Deguchi Y; Kimura R; Matsushima H; Higuchi S; Inagaki O; Honda K; Takenaka T
    Life Sci; 1998; 63(24):2147-55. PubMed ID: 9851306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo measurement by [3H]Tamsulosin of alpha1 adrenoceptors in rat tissues in relation to the pharmacokinetics.
    Yamada S; Ohkura T; Deguchi Y; Kimura R
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1575-83. PubMed ID: 10336555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acids of the human alpha1d-adrenergic receptor involved in antagonist binding.
    Nagaoka Y; Ahmed M; Hossain M; Bhuiyan MA; Ishiguro M; Nakamura T; Watanabe M; Nagatomo T
    J Pharmacol Sci; 2008 Jan; 106(1):114-20. PubMed ID: 18187928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine alpha1-adrenoceptor subtypes. I. Radioligand binding studies.
    Yang M; Reese J; Cotecchia S; Michel MC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):841-7. PubMed ID: 9694940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity specific [3H]tamsulosin binding to alpha 1-adrenoceptors in human prostates with benign prostatic hypertrophy.
    Yamada S; Tanaka C; Ohkura T; Mori R; Kimura R; Inagaki O; Honda K; Kawabe K
    Urol Res; 1994; 22(5):273-8. PubMed ID: 7533443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two district alpha(1)-adrenoceptor subtypes in the human prostate: assessment by radioligand binding assay using 3H-prazosin.
    Maruyama K; Fukutomi J; Chiba T; Yamaguchi M; Takeda M; Hattori K; Nagatomo T
    Gen Pharmacol; 1996 Dec; 27(8):1377-81. PubMed ID: 9304410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamsulosin: alpha1-adrenoceptor subtype-selectivity and comparison with terazosin.
    Muramatsu I; Taniguchi T; Okada K
    Jpn J Pharmacol; 1998 Nov; 78(3):331-5. PubMed ID: 9869267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia.
    Yamada S; Ohkura T; Kimura R; Kawabe K
    Life Sci; 1998; 62(17-18):1585-9. PubMed ID: 9585140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the alpha1L-adrenoceptor in rat cerebral cortex and possible relationship between alpha1L- and alpha1A-adrenoceptors.
    Morishima S; Suzuki F; Yoshiki H; Md Anisuzzaman AS; Sathi ZS; Tanaka T; Muramatsu I
    Br J Pharmacol; 2008 Apr; 153(7):1485-94. PubMed ID: 18223667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.
    Davis BJ; Wiener M; Chapple CR; Sellers DJ; Chess-Williams R
    Auton Autacoid Pharmacol; 2015 Apr; 34(3-4):41-9. PubMed ID: 25790239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.